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1. Introduction
Innovation is widely acknowledged as the key for 
achieving and sustaining a firm’s competitive advan-
tage. It is thus not surprising that innovation is often 
one of the top priorities for many companies, even dur-
ing economic downturns (Scheck and Glader 2009). In 
recent global surveys conducted by McKinsey (Barsh 
et al. 2007) and Boston Consulting Group (Andrew 
et al. 2007), the majority of responding business lead-
ers representing almost all industries considered in-
novation important or even critical to their businesses, 
and they planned to increase future spending on such 
activities.
Despite the growing importance of innovation to 
business success, few companies seem to innovate well. 
It was estimated that the success rate of innovation ini-
tiatives across all industries is only about 4.5% (Van-
Gundy 2007). Senior managers are often unsure of the 
financial return on R&D spending, or whether they are 
satisfied with the efficacy of their innovation programs 
as evidenced by the results from the McKinsey and BCG 
surveys. Although R&D spending continues to rise in a 
large number of companies, its output often falls short 
of expectations. As Andrew and Sirkin wrote in their 
recent book Payback: Reaping the Rewards of Innovation, 
“most attempts at innovation fail to deliver this return—
they do not generate enough payback” (2007, p. 1). 
They believe that true innovation is not just about new 
ideas, but more importantly, about the capability to con-
vert the ideas into cash or profit. Similarly, O’Brien ar-
gues “Being an effective innovator requires more than 
just developing new products: it requires getting those 
products to market” (2003, p. 420).
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Despite the widely held belief of the importance of innovation, the connection between innovation and firm 
performance is empirically inconclusive, partially owing to the limitations of existing innovation measures, 
which tend to ignore the effectiveness of innovation programs. In this study, we use the winning of innovation 
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dian) change in sales, cost per dollar of sales, and Tobin’s Q are 39.28% (20.71%), −5.52% (−3.80%), and 23.70% 
(3.16%), respectively. Panel data regression analysis provides additional insights on the performance impact of 
effective innovation programs. The results show that award winners are not only financially more successful 
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short term and long term.
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The high failure rate of innovation initiatives offers 
a possible explanation of the mixed results of prior re-
search on the link between innovation and performance 
outcome (Capon et al. 1990, Durand et al. 2008, Li and 
Atuahene-Gima 2001). Although useful, existing mea-
sures of innovation employed to test this relation of-
ten do not adequately capture the notion of innova-
tion effectiveness. For example, input-based measures, 
such as R&D expenditures or R&D intensity, only pro-
vide information about a firm’s innovative efforts, but 
do not reveal whether or not the firm is good at being 
innovative. Innovative efforts, however, do not always 
translate to improved performance. Terwiesch and Ul-
rich (2009) showed that there is no clear linkage be-
tween R&D spending and firm performance (revenue 
growth) in a variety of industries, such as computers, 
chemicals, pharmaceuticals, and autos. In their study 
of 1000 publicly held companies around the world that 
spent the most on research and development, Jaruzelski 
et al. (2005) found R&D spending does not affect corpo-
rate success in growth, profitability, and shareholder re-
turn. Higher R&D expenditures may indicate a higher 
level of agency costs (Jensen and Meckling 1976) but not 
necessarily better innovation ability (Kochhar and Da-
vid 1996). Similarly, the connection between output-
based measures, such as patent counts and innovation 
effectiveness, is also weak (Griliches 1990). As shown in 
previous work (Harhoff et al. 1999), the quality and eco-
nomic value of patents can vary greatly with some pat-
ents being extremely valuable while others being worth 
almost nothing. As such, a simple aggregation of pat-
ents does not truly reflect their overall utility.
Innovation can be viewed as a two-staged process 
(Edwards and Gordon 1984, MacLaurin 1953). The first 
is the invention stage where the focus is on basic re-
search (e.g., compound screening for pharmaceutical 
companies). However, identifying a new compound 
does not necessarily deliver value to consumers. Be-
fore the company is able to introduce a successful drug 
based on the compound, it has to link the compound’s 
use to a specific customer demand, conduct preclin-
ical and clinical trials, and fulfill strict government re-
quirement (cf. Girotra et al. 2007). Our study focuses on 
this second stage—commercialization (or development 
for commercial use). It is important to note that patent 
counts or patent citations reflect the outcome of mainly 
the invention part, but indirectly the commercialization 
part of the innovation process. While most of the stud-
ies in the literature have focused on linking patents or 
patent citations to firm performance, our study provides 
direct evidence on how innovation through product de-
velopment and commercialization adds value to firms.
In this study, we seek to justify the returns of an ef-
fective innovation program, which we define as an inno-
vation program that can generate high-impact commer-
cial output and offer substantial value to customers or 
the market. This focus is theoretically important because 
although there has been a conceptual account of the 
general importance of innovation in the field, the em-
pirical evidence remains inconclusive. Furthermore, the 
underlying mechanisms and value of innovation have 
not yet been fully elucidated. Among issues that have 
not been addressed are how innovation matters to firm 
operations, what the magnitude of these effects is likely 
to be, and whether these effects endure, to mention just 
a few. The lack of progress on these fronts is partially 
owing to the fact that high-impact innovations are out-
numbered by minor, less influential ones. This, when 
combined with the limitations of the existing innovation 
measures, obscures the effect of innovation on firms.
Our goal of this study is to fill the gap in the litera-
ture. We use the winning of innovation awards as a 
proxy for the effectiveness of the innovation process.1 
Based on a test sample of 1141 publicly traded firms that 
won innovation awards during 1998–2003 and their ac-
counting and financial data, we empirically examine the 
innovation’s impact on firm performance. Our results 
suggest that effective innovation does pay off. As com-
pared with several sets of control firms, the performance 
of the award-winning firms examined in this study 
shows significant improvement.
There are two major reasons for our choice of award 
winning, instead of traditional innovation measures, 
such as R&D spending or patent counts, as evidence of 
effective innovation programs. First, award providers 
commonly use objective and rigorous evaluation criteria 
or surveys of consumers in choosing award winners. To 
maintain reputation and credibility of their awards, pro-
viders are strongly motivated to award only those firms 
that are truly innovative (see Hendricks and Singhal 
1996, 1997b, and Klassen and McLaughlin 1996 for sim-
ilar arguments for quality and environmental awards). 
For example, the DuPont Award for Innovation in Pack-
aging rewards “innovative products and processes re-
sulting in breakthroughs in sustainable packaging.” The 
Nova Award administered by the Construction Inno-
vation Forum is established to “recognize innovations 
that have proven to be significant advances that have 
had positive, important effects on construction to im-
prove quality and reduce cost.” Computerworld selects 
its Innovative Technology Award winners based on a 
three-stage process, which starts with an industry-wide 
customer nomination, continues on with surveys, and 
finalizes with expert evaluation. During the process, all 
candidates are fully evaluated based on the innovative-
ness and originality of their technology, competitive ad-
vantage, customer satisfaction, and business impact. 
Hence, winning an innovation award provides credible, 
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independent external validation about a firm’s innova-
tion commitment and ability.
Second, the measure of innovation awards takes 
into consideration some nuanced, but important, dif-
ferences between innovation and invention, two in-
terrelated, but conceptually distinct constructs. There 
is a general consensus among business and econom-
ics researchers that an innovation is not merely some-
thing new. MacLaurin argued in his early work that 
“When an invention is introduced commercially as a 
new or improved product or process, it becomes an in-
novation” (1953, p. 105). Likewise, Edwards and Gor-
don claimed that innovation is “a process that begins 
with an idea, proceeds with the development of an in-
vention, and results in the introduction of a new prod-
uct, process or service to the marketplace” (1984, p. 1; 
see also Danneels 2002, Katila and Shane 2005, Thorn-
hill 2006). Therefore, beyond the newness of the idea, 
commercial application is a defining characteristic of 
innovation. Award-giving organizations generally in-
corporate commercial feasibility as a prerequisite for 
their award consideration. To illustrate, again we can 
use the Innovative Technology Award as an example. 
The award provider, Computerworld, highlights in its 
evaluation criteria that each qualified candidate should 
be able to show some evidence of successful commer-
cial use of its technology.2 Thus, such practice and re-
quirement associated with innovation awards supports 
the content validity of the instrument.
By focusing on third-party certified award-winning 
innovations, our study provides a benchmark of what 
can be expected from an effective innovation program. 
It also helps in resolving the controversy about the mag-
nitude of financial returns from innovation. In addition, 
by using publically available data on firms’ innovation 
effectiveness and their financial performance, we avoid 
the potential biases associated with surveying the firms 
to obtain their self-reported perceived innovation effec-
tiveness and financial performance.
The next section provides a summary of the relevant 
literature on innovation. This is followed by a compar-
ison of major existing innovation measures in Section 
3. Section 4 develops the hypotheses. The sample col-
lection and methodology are then detailed in Section 5. 
Section 6 discusses the results. The closing section dis-
cusses the implications and limitations of the study and 
suggests directions for future research.
2. Related Literature
The literature on innovation is vast and growing. 
Among this large body of work, a substantial propor-
tion of the research has focused on why firms differ in 
their innovation effort and commitment. O’Brien (2003), 
for example, found that financial slack constitutes a vital 
complement to the successful execution of innovation 
programs. Pennings and Harianto (1992) and Goes and 
Park (1997) showed that social capital, through its im-
pact on knowledge access and diffusion in the market, 
plays a critical role in a firm’s decision to adopt a new 
product or service. Leiponen (2008) echoed the impor-
tance of social relations, but from a different perspec-
tive. The author detected that the willingness of a com-
pany to make investments on innovation is shaped by 
its ability to control knowledge output from collabora-
tive relations.
A firm’s propensity to innovate also appears to be 
contingent on its own strategic choices and orientation 
(Ahuja and Katila 2001, Hitt et al. 1997, Thornhill 2006). 
Hitt et al. (1997) argued and found evidence that inter-
nationally diversified firms are more inclined to fund re-
search and development because the broadness of their 
business scope allows them to take full advantage of 
such effort. Ahuja and Katila’s (2001) insightful analysis 
showed that technological acquisition can both broaden 
firms’ knowledge stock and disrupt their operating rou-
tines; thus it can affect innovation outcome in such a 
complicated fashion that its ultimate impact is deter-
mined by both the absolute and relative size of the ac-
quired knowledge base.
Still, many other factors matter to innovation output. 
Among the other factors that have been studied are: ex-
ecutive pay (Balkin et al. 2000), organizational struc-
ture (Jansen et al. 2006), manager background (Bantel 
and Jackson 1989), internal resource exchange (Tsai and 
Ghoshal 1998), institutional investors (Kochhar and Da-
vid 1996), market competitiveness and size (Katila and 
Shane 2005), and industry dynamism (Thornhill 2006).
Given the above findings, firms would naturally dif-
fer in their innovation activities. This gives rise to a 
question of whether the disparity has a performance im-
plication to firms. Through a comprehensive (but not 
necessarily exhaustive) review of the literature, we iden-
tified 26 studies (summarized in Table 1)3 that have em-
pirically investigated this question. Together, the evi-
dence generally supports the argument that innovation 
is essential to organizational survival and long-term 
success. Innovating firms are characterized by higher 
stock performance and stronger ability to capture mar-
ket opportunities (Banbury and Mitchell 1995, Kelm 
et al. 1995, Lawless and Anderson 1996, Zhao 2009). For 
example, Zhao (2009) found the level and dynamics of 
technological innovation is an important predictor of 
the future value of a firm’s stock. Kelm et al. (1995) em-
pirically showed that the capital market tends to posi-
tively react to firm announcements of R&D projects. On 
studying 86 firms in the U.S. implantable cardiac pace-
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maker industry over a 31-year period, Banbury and 
Mitchell (1995) observed that the more active a firm is 
in pursuing product innovation, the greater the market 
share it is likely to achieve.
Firms that strive to reach and maintain a high level 
of innovativeness also often exhibit better economic 
performance than less-innovative firms. By compar-
ing four groups of Fortune 500 manufacturers, which 
have different levels of research commitment, Capon 
et al. (1992) found firms with the highest R&D spend-
ing enjoy greater profitability than the others. Roberts’s 
(1999) longitudinal study of pharmaceutical companies 
reveals that firms possessing the capacity to innovate 
continuously over time are financially more successful. 
Yet the available evidence is not always consistent (see, 
e.g., Durand et al. 2008, Leiponen 2000, Loch et al. 1996, 
Terwiesch et al. 1998). A recent study by Durand et al. 
(2008) surprisingly shows that the number of patents a 
firm owns has a depressing effect on its short-term per-
formance. Terwiesch and his colleagues (Loch et al. 
1996, Terwiesch et al. 1998) found that in the electron-
ics industries, innovation-related development intensity 
cuts down firm profitability.
Despite the general observation of the importance 
of innovation, the specific underlying mechanisms of 
the innovation process and its impact on operating ef-
ficiency are far less understood. It is not clear whether 
the observed positive performance impact of innova-
tion is caused by a rise of revenue associated with the 
increased image of the firm in the market, or a reduction 
in operating costs engendered by improved efficiency, 
or both. Although there are a handful of studies that do 
link innovation to sales, the results of these studies are 
often weak and inconsistent. For example, using a sur-
vey of 877 small and medium sized firms in Taiwan, Lin 
and Chen (2007) found that with the exception of ad-
ministrative innovations, other forms of innovations do 
not have an influence on company sales. Freel’s (2000) 
study of new product introductions by 228 small manu-
facturing firms in England shows that although innova-
tors enjoy higher employment growth and productivity, 
they do not differ from non-innovators in terms of sales 
growth, profitability, or export performance.
The mixed empirical evidence of the effect of innova-
tion on firm performance is possibly due to the inade-
quacy of the measures adopted by previous studies. In 
the section below, we briefly review some of the popu-
lar measures that have been applied in the literature.
3. Measures of Innovation
A variety of measures have been proposed and em-
ployed for analyzing the notion of innovation, includ-
ing, among others, R&D spending, patents, and new 
product introductions (see column 2 in Table 1). Al-
though each of the available measures opens a win-
dow for studying innovation, none of them are above 
criticism. For instance, there are a couple of shortcom-
ings of R&D spending, one of the most commonly used 
measures in the innovation literature. First, as an input 
variable in the innovation process, R&D only reflects a 
firm’s effort to carry out research programs, but it does 
not necessarily indicate the firm’s innovation ability and 
output (Kochhar and David 1996). In fact, firms with 
the same amount of R&D spending may have substan-
tially different innovation performance given the dis-
parity of their abilities to organize, arrange, and inte-
grate resources for knowledge creation. Second, the 
requirement for R&D investment may vary markedly 
from one industry to another. Balkin et al. (2000) em-
pirically showed that high-technology firms are more 
likely to provide incentives to induce CEOs to channel 
resources to R&D projects as compared with their low-
technology counterparts. The authors reasoned that, in 
segments where knowledge is a key competitive factor 
and changing rapidly, it is typically difficult, yet impor-
tant, for firms to maintain a technological edge against 
rivals. Under this condition, large expenditures in R&D 
are desirable and conducive to firms. The variation in 
firm practices and policies associated with the state of 
market conditions thus makes it hard to meaningfully 
compare R&D spending across industries.
Given the drawbacks of R&D spending, researchers 
have turned to using patent data as an alternative ap-
proach. Unlike R&D spending, patents manifest some 
outputs of the innovation process. Although this fo-
cus allows the instrument to get around some of the 
problems inherent in R&D spending, patents also suf-
fer a few limitations. Griliches (1990, p. 1666) explicitly 
pointed out that “patents differ greatly in their techni-
cal and economic significance. Many of them reflect mi-
nor improvements of little economic value. Some of 
them, however, prove extremely valuable.” Harhoff 
et al.’s (1999) survey confirms this argument and shows 
that, from the owner’s perspective, the value conveyed 
by patents does diverge considerably. There is also evi-
dence that the quantity of patents a firm owns does not 
predict well firm value (LeVine 2010). These observa-
tions thus question the validity of using simple patent 
counts as a proper indicator of innovation capacity.
In comparison, patent citations constitute a more so-
phisticated use of patent data. As a main advantage, 
this approach offers a clear, objective way to guage and 
control for the discrepancy in importance of patents by 
weighting them according to how frequently they are 
cited by others. However, like other patent-based mea-
sures of innovation, the citation index, too, focuses on 
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innovations at the invention stage, but rarely on the 
commercialization part of the innovation process. Fur-
thermore, this index rests on the assumption that firms 
pursue patent protection for all their innovations (Zie-
donis 2004). Yet, the assumption of unselective patent-
ing is questionable because patenting is not always nec-
essary or desirable. In practice, firms may decide not to 
patent their products, services, technologies, processes, 
or business methods for confidentiality or growth consid-
erations (Heeley et al. 2007, Kumar and Turnbull 2008). 
Conversely, even if firms do file patent applications, they 
may choose to do so for different motives. For example, 
in industries where technology is complex—namely, in-
novation involves multiple complementary technological 
components, patenting is commonly used to disrupt or 
restrict rivals’ research agendas, to increase negotiation 
power, and to create cross-licensing opportunities (Clark 
and Konrad 2008, Heeley et al. 2007). In this context, the 
value of patents is hard to be assessed and compared.
Moreover, recent studies have shown that a patent’s 
citations may stem not only from its technological im-
portance and viability but also from many other sources 
like “publicity, licensing practices, interconnectedness, or 
other technological features” (Rysman and Simcoe 2008, 
p. 1925, also Rosenkopf and Almeida 2003, Singh 2005). 
In other words, the justification of citations as an effective 
proxy for patent quality may not be taken for granted.
Two other well-established measures in the field are 
new product introductions and survey-based measures. 
Proponents of the former approach hold that the rate 
at which a firm introduces new products as well as the 
radicalness of the products (i.e., whether they are new 
to the firm, new to the market, or new to the world) sig-
nals the firm’s innovative ability. Nevertheless, innova-
tion is not necessarily confined to product development; 
rather, it could also relate to methods of production, 
market expansion, sources of supply of raw materials, 
and organization forms (Bantel and Jackson 1989, Goes 
and Park 1997, Phene et al. 2006). In this regard, the 
measurement of new product introductions is narrowly 
focused. Survey instruments, by contrast, offer a more 
general way to investigate innovation behaviors. These 
tools are often flexible to be modified to fit different re-
search settings and foci. They also allow direct data ac-
cess from innovators and enable collection of detailed 
information, which is usually not accessible through 
other means or channels. However, survey measures are 
self-reported. The reliance on subjective assessment of 
organization members may lead to serious problems be-
cause what is perceived by the firm as highly innova-
tive may be considered quite differently by the market. 
In addition, the methodology itself is potentially subject 
to the problem of common method bias.
Thus far, we have shown that it is difficult, if not im-
possible, to create a generalizable innovation measure-
ment applicable to all organizations and circumstances. 
That said, our intention is not to dispute the importance 
of existing measures, such as those mentioned above; 
their value and contributions have already been recog-
nized in the literature. From a practical standpoint, all 
these measures provide reasonable ways to test inno-
vation-related phenomenon, although each of them re-
veals only part of the complete picture. Given the rich-
ness of the notion of innovation, we contend that a 
diversity of measurements is necessary and beneficial 
to the development of the field. For example, innovation 
awards could represent a useful complement to patents 
and patent citations, given their properties and selection 
mechanisms. Although patents and patent citations are 
reasonable indicators of the output mainly from the in-
vention part of the innovation process, the use of inno-
vation awards can provide a more direct measure of ef-
fective innovation because of the clear focus of award 
givers on the commercial application of new products 
or services. Table 2 provides a detailed comparison of 
major innovation measures.
4. Hypotheses
Award-winning innovations are non-trivial ones. They 
tend to be influential in the sense that their adoption 
and application can have a significant impact on busi-
ness trend, customer choice, or the way firms compete 
in the market. Winning an innovation award reflects a 
firm’s commitment to highly innovative programs, as 
well as how successfully these programs have been im-
plemented. Although innovation is conducive to firms 
(Hull and Rothenberg 2008, Roberts 1999, Thornhill 
2006), the benefits of undertaking effective innovation 
Table 2. Comparison of Innovation Measurements
Innovation	measurements	 Innovation	awards	 R&D	spending	 Patents	 New	products	 Survey
Input	vs.	output	 Output	 Input	 Output	 Output	 Both
Development	stage	 Commercialization	 Mostly	invention	 Invention	 Commercialization	 Both
Scope	of	innovation	 Broad	 Unclear	 Broad	 Narrow	(products)	 Broad
Subjective vs. objective Objective Objective Objective Objective Subjective
High-impact	vs.	minor	innovations	 High-impact	innovations	 Unclear	 Both	 Both	 Both
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programs may be even greater given the quality of the 
outputs of such programs. Hence, innovation award 
winners should be able to distinguish themselves fi-
nancially from peer firms that are not honored by such 
awards. In keeping with prior research (Cho and Pucik 
2005, Roberts 1999), we measure profitability by return 
on assets (ROA), which is income before extraordinary 
items4 divided by total assets, and return on sales (ROS), 
which is income before extraordinary items divided by 
net sales. As it is likely that a firm’s profitability is af-
fected by its choice of depreciation method, we also use 
operating income (which is before depreciation) as an 
alternative measure of profitability.
Hypothesis 1. Conducting an effective innovation pro-
gram will increase a firm’s profitability.
It is important to note that although analogous hy-
potheses have been tested in prior research, Hypothesis 
1 is worth studying for its own sake. In fact, most of the 
past work has focused on R&D spending, new product 
introduction, and patents, which have limitations as we 
have noted above. In addition, recent research shows 
that innovations are dissimilar in terms of their impact 
and utility (Govindarajan and Kopalle 2006, Phene et al. 
2006). Unlike their major counterparts, minor innova-
tions only confer limited benefit to firms, whose value 
tends to evaporate quickly.5 Indeed, Roberts and Amit 
(2003) found that just being the first to adopt an inno-
vation does not naturally bring a competitive advantage 
to a firm. In this light, a holistic approach of aggregat-
ing all innovations may not be ideal as this may obscure 
the effect of those larger, more influential ones. Despite 
the conceptual importance of high-impact innovations 
(Schumpeter 1934), no empirical study to date has spe-
cifically examined how these innovations may contrib-
ute to firms and what the magnitude of their impact 
would be. Innovation awards help weed out low-impact 
innovations and thus offer an avenue to fill the void.
Hypothesis 1 establishes a baseline hypothesis, yet 
the relationship between innovation awards and prof-
itability could be more elaborate and complex than it 
appears. First-mover advantage theorists (Lieberman 
and Montgomery 1988, Song et al. 1999) posit that in-
novation-related activities can promote a company’s 
brand image and visibility. As a result, firms that are 
active in innovation can charge premium prices by in-
fluencing the way consumers perceive the value of 
their products or services. The anticompetition per-
spective (Roberts 1999) arrives at a similar conclusion 
from a different angle. Anchored in industry organiza-
tion economics, this view speculates that innovations 
can function as a critical means of deterring rival en-
try. On one hand, participating in innovation can foster 
knowledge creation, which allows firms to use patents 
to protect their market positions; on the other hand, 
such activity can strengthen customer loyalty, mak-
ing it more costly and less beneficial for other firms 
to compete in the same market. Together, these argu-
ments suggest that innovation may generate higher 
revenue for the firm. We expect that the magnitude of 
this benefit would be more significant and notable for 
firms with a more effective innovation program. We 
use net sales to measure revenue.
Hypothesis 2. Conducting an effective innovation pro-
gram will increase a firm’s revenue.
An award-winning innovation program may render 
a cost benefit as well. According to the competence re-
newal perspective on innovation (Danneels 2002), inno-
vation could serve as an important vehicle for organiza-
tional learning and renewal. This argument is consistent 
with the theory of dynamic capabilities and the liter-
ature on absorptive capacity (Cohen and Levinthal 
1990, Teece et al. 1997), both of which posit that firms 
are evolving systems and can constantly update their 
knowledge and skills. By definition, innovation implies 
a deviation from conventional course of behaviors. To 
be productive in this effort, firms need to question their 
own assumptions and premise of existing practices. This 
process forces firms to think about new ways of com-
bining resources and re-link knowledge components, 
which creates opportunities for improving operational 
efficiency. Innovation also puts a demand on coordi-
nation among separate units within the firm (Danneels 
2002). Hence, an effective award-winning innovation 
program could facilitate inter-unit communication and 
idea exchange, accelerating knowledge sharing and in-
tegration. As a consequence, new technologies or skills 
may emerge, which can improve product quality, re-
duce defects, streamline manufacturing process, and 
lower production costs (Cho and Pucik 2005, Lieberman 
and Montgomery 1988). We follow Hendricks and Sing-
hal (1997b) to use cost per dollar of sales, defined as the 
sum of cost of goods sold plus selling, general, and ad-
ministrative expenses divided by net sales, as a measure 
of operating cost.
Hypothesis 3. Conducting an effective innovation pro-
gram will reduce a firm’s operating costs.
The benefits of effective innovation programs men-
tioned above should open up to firms with more growth 
opportunities. Hence, we expect award-winners to have 
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a higher financial market valuation than other firms. We 
use Tobin’s Q as a measure of a firm’s market valuation 
and growth potential. It is calculated as the ratio of the 
market value of a firm’s debt and equity to the current 
replacement cost of its assets (Corbett et al. 2005).
Hypothesis 4. Conducting an effective innovation pro-
gram will increase a firm’s Tobin’s Q.
5. Methodology
5.1. Data Collection
The first step in the data collection process was to ob-
tain a comprehensive list of firms that had won innova-
tion awards between 1998 and 2003. Our primary source 
for identifying such firms is the Dow Jones Factiva, an 
online search database containing news sources from 
Associated Press, Business Wire, Dow Jones News Ser-
vice, Financial Times, PR Newswire, and the Wall Street 
Journal. We performed a search using various combi-
nations of key words, such as award, innovation, inno-
vative, design, creative, original, and new product (ser-
vice). This resulted in over ten thousand press releases 
or news articles, each of which was read to determine 
and cross-verify whether firms had actually won inno-
vation awards and, if so, the timing of the award. Some 
examples of press releases are given below. 
●  “Aspen Technology, Inc., the leading provider of 
Smart Manufacturing and Supply Chain Manage-
ment software and services for the process indus-
tries, today announced it has received the Indus-
try Week Technology of the Year award.” Business 
Wire, Dec. 22, 1998.
●  “NMS Communications, a leading supplier of tech-
nology for tomorrow’s networks, today announced 
that its Packet Media IP media server development 
platform has won the Product of the Year award 
presented by Internet Telephony Magazine.” Busi-
ness Wire, December 19, 2000.
●  “Jasc Software, Inc. today announced that it received 
the CNET Editors’ Choice award for its Paint Shop 
Photo Album 4. CNET Editors’ Choice winners are 
recognized as top products in their respective tech-
nology categories, and contribute to the standard 
by which all future products are judged. A key se-
lection requirement is the difference it makes in the 
lives of its users, whether through innovative fea-
tures, exceptional value for the price, remarkable 
ease of use, or a demonstrable boost to users’ pro-
ductivity.” PR Newswire, March 14, 2003.
A total of 6219 distinct award-winning firms were 
found from this initial search.
The financial and accounting data for these firms 
were then retrieved from COMPUSTAT. Among the 
6219 firms, 1141 firms were listed on the COMPUSTAT 
database. These firms represent a wide range of indus-
tries in both the manufacturing and service sectors. Ta-
ble 3a depicts the distribution of the sample firms by 
year. From 1998 to 2003, the percentage of firms in the 
sample generally increases from 6.5% to nearly 30%. 
Table 3b shows the distribution of the sample firms by 
2-digit SIC code. The sample firms are fairly well rep-
resented across different industries. The highest con-
centration is in manufacturing (593 firms, 52%) and 
services (341 firms, 30%), and the lowest is in construc-
tion (5 firms), public administration (5 firms), and min-
ing (9 firms).
The performance metrics used in this study include 
operating income, sales, ratio of total cost to sales, To-
bin’s Q, and return-based measures, such as ROA and 
ROS. These variables have been widely used in the 
strategy and operations management literatures (e.g., 
Cho and Pucik 2005, Corbett et al. 2005, Hendricks et al. 
2007), and reflect different aspects of the outcome of 
business operations, that is, profitability, revenue, cost 
efficiency, and market value.
Table 3a. Distribution of Sample Firms by Year
Year	 Frequency	 Percent
1998	 74	 6.49
1999 112 9.82
2000	 175	 15.34
2001	 222	 19.46
2002 219 19.19
2003 339 29.71
Total	 1141	 100.00
Table 3b.	Distribution	of	Sample	Firms	by	2-Digit	SIC	Code
SIC	Code	 Industry	 Frequency	 Percent
10–14	 Mining	 9	 0.79
15–17	 Construction	 5	 0.44
20–39 Manufacturing 593 51.97
40–49	 Transportation,		 81	 7.10 
 Communications,  
 Electric, Gas, and  
 Sanitary Services
50–51	 Wholesale	Trade	 26	 2.28
52–59	 Retail	Trade	 35	 3.07
60–67	 Finance,	Insurance,		 46	 4.03 
 and Real Estate 
70–89	 Services	 341	 29.89
91–99	 Public	Administration	 5	 0.44
		 Total	 1141	 100
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We tracked a firm’s performance change over an 
8-year period because the effect of an innovation pro-
gram may not be able to manifest in a short time, espe-
cially for those award winners whose winning prod-
ucts and services are new to the market. Specifically, the 
evaluation period starts 4 years before and ends 3 years 
after the year when the firm received its first innovation 
award. Similar pre- and post-implementation time pe-
riods have been used in several other studies, such as 
Corbett et al. (2005) and Hendricks et al. (2007). To pool 
observations over time, we translated the calendar year 
to an event year for each firm, with year 0 being defined 
as the year the firm received the award, year ±1 as the 
year after/before the award, year ±2 as the second year 
after/before the award, and so on.
5.2. Control Firm Selection
To examine the benefits of an award-winning innova-
tion program, it is critical to compare the performance 
of award-winning firms with that of a group of carefully 
chosen control firms. The purposes of using the control 
group are to provide a benchmark for the performance 
of the sample firms and to control for potential industry 
and/or economy-wide effects on a firm’s performance 
that may have nothing to do with innovation effective-
ness. An ideal control firm would be the one that is iden-
tical to the sample firm in every aspect of business, ex-
cept that it has not won an innovation award. Such an 
ideal firm, however, does not exist. Hence, control firms 
are commonly selected to match sample firms as closely 
as possible in several key dimensions, such as industry, 
size, and pre-event performance (Corbett et al. 2005, Hen-
dricks et al. 2007). Total assets are often used as a proxy 
for firm size, whereas the ROA6 is a preferred measure of 
performance in choosing control firms (Barber and Lyon 
1996, Corbett et al. 2005). In innovation research, the R&D 
spending or intensity is often found to be an important 
factor that can influence the innovation outcome and it 
can vary widely among firms even in the same industry. 
Barber and Lyon (1996) find that matching by firm size in 
addition to industry and ROA provides little or no extra 
benefit. Therefore, we used the R&D intensity (defined 
as the ratio of R&D spending to sales) instead of the firm 
size as one of the criteria to identify control firms. Thus, 
a control firm in our study is the one in the same indus-
try that is closest to the award-winning firm in ROA and 
R&D intensity. In addition, although one-to-one match-
ing is common in the literature, using a matching portfo-
lio of similar firms often yields more powerful test statis-
tics (Alderson and Betker 2005). Therefore, we considered 
both one-to-one and one-to-portfolio matching methods 
in this study. In all cases, the year proceeding the award 
year was used as the basis to select control firms.
Following Corbett et al. (2005), we used the following 
steps to select control firms: 
●  Inside the same 2-digit industry of each sample firm, 
we identify control firms whose ROA is within 90% 
and 110% times ROA of the sample firm and whose 
R&D intensity is within 0.7 and 1.3 times the R&D 
intensity of the sample firm.
●  In one-to-one matching, we first calculate for each 
firm the z-scores for ROA and R&D intensity (de-
fined as the ratio of the difference between the 
ROA [R&D intensity] and the industry mean to 
the industry standard deviation), and then com-
pute the Euclidean distance in the two-dimen-
sional space of z-scores. The matching firm is the 
one whose Euclidean distance is closest to that of 
the sample firm.
●  In one-to-portfolio matching, all the firms identified 
in step (1) are chosen as the control firms.
●  If for some sample firms, no control firms could be 
identified in (1), the industry is relaxed to a one-
digit SIC and then the procedure is repeated.
5.3. Abnormal Performance Measure and Analysis
We first employ the event-study method to assess the 
abnormal performance of award-winning firms. Like 
other studies using the same approach (e.g., Hen-
dricks and Singhal 1997b, Hendricks et al. 2007), we 
define a sample firm’s abnormal performance as the 
percentage change in the firm’s performance minus 
the percentage change in the control firm’s perfor-
mance. More specifically, we calculate the abnormal 
performance measure as
PMSt1 – PMSt2  –
  PMCt1 –  PMCt2
PMSt2                    PMCt2
where PMSt1 (PMCt1) is the performance measure for 
the sample (control) firm in year t1 and PMSt2 (PMCt2) is 
the performance measure for the sample (control) firm 
in year t2.
To control for the effect of potential outliers, all ab-
normal performance measures are trimmed symmetri-
cally at the 2.5% level in each tail. Even with the trim-
ming, the data may still not be symmetric and outliers 
may still be an issue. For this reason, we report both 
parametric and non-parametric testing results. The 
parametric test is based on the normal t-test on changes 
in the mean, and the non-parametric test we employed 
is the Wilcoxon signed-rank (WSR) test. These tests are 
used to analyze whether the median of the changes is 
significantly different from zero. It is important to note 
that because of the matching requirements, the missing 
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of data for calculation, and the data trimming, the sam-
ple sizes actually used in the event study analysis vary 
depending on which performance metric is used and 
what time interval is considered.
5.4. Panel Regression Analysis
Although our choice of the event-study method is moti-
vated and justified by earlier research with a similar in-
terest in quality awards and certifications (Corbett et al. 
2005, Hendricks and Singhal 1997b), firms’ R&D activ-
ity can vary over time rather than being static as as-
sumed by the event-study approach.7 For this reason, 
we also conducted panel data analysis. Specifically, we 
used two-way fixed effects models to control for sources 
of unobserved heterogeneity. This approach also ac-
counts for possible non-independence of observations 
that share the same sources of variance. The basic model 
form can be written as:
        PM =  R&D + β Award Dummy  
                                + γ R&D × Award Dummy  
                                + Σi θi Control Variablei + Error 
where PM represents the performance measure variable, 
such as ROA; R&D is the R&D intensity; AwardDummy 
is the award winning dummy variable; , β, γ, and θ rep-
resent model coefficients. The model directly builds up 
the relationship between the inputs and outputs of inno-
vation program with the award winning dummy serv-
ing as a moderator. The coefficient on the interaction be-
tween R&D and AwardDummy should capture the extra 
returns to R&D investment for award-winning firms.
We considered a number of control variables at both 
the firm and industry levels. The natural logarithm of 
total sales was included to account for firm size. Strate-
gic alliance formation could affect firm performance one 
way or another (Stuart 2000, Yu et al. 2011). Thus, we 
included in the model an alliance variable, which was 
coded as the total number of alliances formed by a firm 
in a 5-year window8 preceding each observation year. 
Alliance data were obtained from the Securities Data 
Company (SDC) database. A Herfindahl index of diver-
sification was used in our analysis to capture the poten-
tial diversification effect as predicted by previous re-
search (e.g., Rumelt 1982). In addition, we controlled for 
financial leverage, plant and equipment (P&E) newness, 
and capital intensity. Financial leverage was measured 
as total debt divided by total assets. P&E newness was 
measured as new P&E divided by gross P&E. Capital 
intensity was calculated as the ratio of the net value of 
property, plant, and equipment to net sales.
To control for possible industry effects on firm perfor-
mance, we further included two industry variables: in-
dustry attractiveness and technology opportunity. The 
industry attractiveness variable was approximated by 
the mean of the ratio of operating profit to sales in each 
industry. Technology opportunity was measured by the 
mean industry R&D intensity. In addition to above firm 
level and industry level factors, we also included year 
and firm dummy variables. These dummies were used to 
account for the unobserved time and firm differences.
All independent variables and control variables were 
lagged to minimize the possibility of reverse causation. 
We estimated models using 1-year lags for all control 
variables while using either 1-year lag or 3-year lag for 
R&D intensity to test for its short-term or long-term ef-
fects. The time period chosen for the analysis was from 
years −1 to +3.
6. Empirical Results
6.1. Results from the Event Study Analysis
We first present results from the event study analysis. 
Because of the similarity in results between one-to-one 
matching and one-to-portfolio matching, we report here 
only the results from the one-to-one matching method. 
Table 4 shows summary statistics for award-winning 
firms and control firms at t − 1.
For each performance measure, we report two sets of 
results. The first is the mean and median of the annual 
difference in the percentage change in performance be-
tween the sample and control firms. These results show 
the year-to-year performance change in the award-win-
ning firms relative to control firms. The second set of 
results report the mean and median of the percentage 
difference in performance between the sample and con-
trol firms over several longer time intervals, such as be-
tween years −1 and +1, −1 and +2, −1 and +3, and −4 
and +3 to reflect different patterns of change in perfor-
mance across firms (see Hendricks and Singhal [1997b] 
for a discussion on using different time intervals to de-
tect changes of performance over time).
Table 5 reports the mean and median changes on 
three return/profitability measures when the control 
firms are selected based on matching on industry, ROA, 
and R&D intensity. Panel A of the table shows the con-
trol adjusted changes on an annual basis over the 8-year 
period starting from year −4 and ending in year +3, 
whereas Panel B gives the results on several longer pe-
riods reflecting the changes from 1 year and 4 years be-
fore the innovation award to 1, 2 and/or 3 years after 
the award. Panel A shows that the annual mean and me-
dian changes in ROA and ROS are all positive and sig-
nificant at the 10% level in most years. It also shows that 
on an annual basis, both the mean and median changes 
in operating income of the award-winning firms are 
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positive and significant at the 5% level in the majority 
of cases. Over the longer time intervals, Panel B shows 
that the mean changes in ROA, ROS, and operating in-
come are all positive and significant in nearly all cases. 
For example, from years −4 to +3, the award-winning 
firms have, on average, about 32.6% higher ROA, 34.5% 
higher ROS, and 39.1% higher operating income than 
the corresponding control firms. The median changes 
in these measures, although still significant at the 5% or 
10% level, have relatively smaller values than the mean 
changes. Overall, the results provide strong evidence 
that the returns on investment for the test firms are sig-
nificantly higher than for the control firms.
Table 6 reports the control adjusted changes in sales, 
total cost/sales, and Tobin’s Q over one-year period 
(Panel A) and over longer time periods (Panel B) when 
the control firms are selected by matching on industry, 
prior performance, and R&D intensity. Panel A shows 
that on an annual basis, both the mean and median 
changes in sales of the award-winning firms are positive 
and significant (p < 0.05) in almost all intervals. For the 
ratio of total cost to sales, the mean changes are negative 
and significant at the 10% level in all years except from 
year 0 to +1. The median changes are negative and sig-
nificant at the 10% level only at years −1 to 0 and +2 to 
+3. The annual mean change in Tobin’s Q is positive in 
all years except from year −4 to −3, but is only highly 
significant at the 1% level for years from +2 to +3, and 
significant at the 10% level from years −3 to −2, −2 to −1, 
and −1 to 0. The annual median change is only signifi-
cant at the 5% level for years +2 to +3.
From 1 year before to 1, 2, and 3 years after winning 
an award, Panel B of Table 6 shows that the mean (me-
dian) changes in sales are positive and significant at the 
1% (10%) level. For the cost per dollar of sales and To-
bin’s Q, the mean changes are significant (p < 0.05 or 
0.10) for all three time intervals, but the median changes 
are not. Over the 8-year period from years −4 to +3, the 
mean (median) control adjusted change in sales is about 
39.3% (20.7%). Over the same period of time, the mean 
Table 4. Descriptive	Statistics	for	the	Sample	Firms	and	Control	Firms	Using	One-to-One	Matching	by	Industry,	ROA,	and	R&D	intensity
  Obs Mean Median SD Minimum Maximum
Sample Firms
ROA	(%)	 360	 3.81	 4.61	 0.09	 −28.03 27.78
ROS	(%)	 360	 3.88	 4.87	 0.11	 −28.65	 40.78
Operating	Income	(million	$)	 493	 269.78	 4.98	 1469.64	 −337.59 19276.00
Sales	(million	$)	 493	 1443.06	 112.95	 7015.81	 0.12	 81186.00
Cost/Sales	(%)	 440	 94.99	 90.04	 22.09	 43.43	 295.87
Tobin’s	Q	 440	 2.11	 1.30	 2.40	 0.03	 15.05
Control Firms
ROA	(%)	 360	 3.75	 4.62	 0.08	 −28.41	 26.33
ROS	(%)	 360	 3.12	 4.40	 0.10	 −34.95	 34.54
Operating	Income	(million	$)	 493	 199.60	 4.70	 1113.03	 −193.11 18632.00
Sales	(million	$)	 493	 1190.05	 95.70	 5901.70	 0.11	 72944.00
Cost/Sales	(%)	 440	 96.23	 90.53	 23.92	 45.27	 424.59
Tobin’s	Q	 440	 1.80	 1.30	 1.79	 0.02	 11.19
Table 5. Mean	and	Median	Control	Adjusted	Percentage	Changes	in	ROA,	ROS,	and	Operating	Income	with	Control	Firms	Selected	by	Industry,	
ROA, and R&D Intensity
 ROA     ROS              Operating income
     WSR      WSR      WSR 
From year Obs Mean Median T-test	 test	 Obs	 Mean	 Median	 T-test	 test	 Obs	 Mean	 Median	 T-test	 test
Panel	A:	Changes	in	Performance	on	an	Annual	Basis
−4	to	−3	 165	 8.16	 7.25	 0.218	 0.609	 165	 9.03	 7.44	 0.224	 0.519	 220	 7.90	 2.21	 0.237	 0.894
−3 to −2	 154	 30.57	 14.65	 0.098	 0.086	 156	 37.88	 17.24	 0.098	 0.056	 242	 15.30	 10.51	 0.009	 0.006
−2 to −1	 181	 12.18	 13.29	 0.083	 0.090	 174	 14.19	 8.86	 0.072	 0.055	 220	 22.35	 14.75	 0.001	 0.008
−1	to	0	 206	 20.30	 14.34	 0.093	 0.098	 203	 22.27	 19.55	 0.084	 0.091	 224	 12.05	 12.03	 0.007	 0.016
0	to	+1	 140	 20.80	 11.90	 0.094	 0.081	 143	 21.68	 11.05	 0.090	 0.086	 176	 24.34	 11.53	 0.023	 0.069
+1	to	+2	 107	 18.98	 13.49	 0.027	 0.081	 106	 17.41	 8.85	 0.053	 0.090	 168	 15.00	 8.29	 0.023	 0.091
+2	to	+3	 112	 28.71	 15.25	 0.098	 0.067	 120	 33.62	 11.45	 0.096	 0.093	 164	 15.60	 10.17	 0.027	 0.297
Panel	B:	Changes	in	Performance	Over	Varying	Time	Periods
−1	to	+1	 205	 30.07	 16.90	 0.097	 0.057	 215	 33.01	 10.70	 0.097	 0.075	 229	 12.94	 11.90	 0.058	 0.062
−1	to	+2	 191	 33.96	 11.16	 0.051	 0.046	 189	 29.27	 7.00	 0.095	 0.080	 184	 15.28	 17.56	 0.077	 0.097
−1	to	+3	 177	 32.43	 18.97	 0.039	 0.042	 175	 34.38	 23.23	 0.061	 0.031	 175	 18.95	 21.70	 0.090	 0.228
−4	to	+3	 112	 32.56	 23.53	 0.010	 0.033	 115	 34.54	 24.11	 0.006	 0.027	 150	 39.11	 36.18	 0.063	 0.089
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(median) change in cost per dollar of sales of the sam-
ple firms is 5.5% (3.8%) lower than that of the control 
firms. These changes are significant at the 5% level. In 
addition, the award-winning firms have about 23.7% 
(3.2%) higher Tobin’s Q than the control firms in control 
adjusted mean (median) with the difference significant 
at the 5% (10%) level.
We have also conducted an extensive set of sensitiv-
ity analyses based on different groups of control firms 
selected with different matching criteria. First, our se-
lection of control firms was based on the firm perfor-
mance and characteristics in the year before the award 
year. Although this is the standard practice in the liter-
ature, the results may be biased because the matching 
does not consider the temporal change in firm perfor-
mance. Award-winning firms may have higher percent-
age change in performance compared with the control 
firms before winning the awards, thus carrying that mo-
mentum into the future. To rule out this possibility, we 
ran analyses based on control firms selected with sim-
ilar percentage changes in ROA and/or R&D intensity 
from year t − 2  to year t − 1 . The results, as shown in 
Tables 7 and 8, are quite similar.
Second, we used the ROA as the measure of perfor-
mance in choosing control firms. Although matching 
based on ROA is an accepted approach, we considered 
other performance measures, such as operating income, 
ROS, sales, and total costs as the basis for the selection 
of control firms. The results are largely unchanged from 
our main results reported earlier and are not reported 
here due to the similarity.
Third, although we define the abnormal performance 
measure as the percentage change in financial perfor-
mance between a sample firm and its control firm at two 
different time periods, abnormal performance can also be 
defined as a simple change in the performance of a sam-
Table 6.	Mean	and	Median	Control	Adjusted	Percentage	Changes	in	Sales,	Cost,	and	Tobin’s	Q	with	Control	Firms	Selected	by	Industry,	ROA,	
and R&D Intensity
	 	 	 Sales	 	 	 	 	Total	cost/sales	 	 	 	 	Tobin’s	Q
     WSR      WSR      WSR 
From year Obs Mean Median T-test	 test	 Obs	 Mean	 Median	 T-test	 test	 Obs	 Mean	 Median	 T-test	 test
Panel	A:	Changes	in	Performance	on	an	Annual	Basis
−4	to	−3	 373	 6.05	 2.52	 0.004	 0.026	 378	 −2.44	 −0.03	 0.016	 0.567	 194	 −2.71 −1.34	 0.298	 0.546
−3 to −2	 407	 8.60	 6.17	 0.000	 0.001	 401	 −1.74	 −0.96	 0.045	 0.103	 216	 8.00	 4.04	 0.073	 0.271
−2 to −1	 448	 7.43	 4.26	 0.000	 0.000	 426	 −1.39 −0.92	 0.077	 0.259	 195	 6.69	 8.39	 0.078	 0.240
−1	to	0	 457	 11.78	 6.63	 0.000	 0.000	 432	 −1.57 −1.44	 0.049	 0.056	 194	 8.02	 4.43	 0.068	 0.409
0	to	+1	 371	 4.73	 0.00	 0.001	 0.234	 368	 0.68	 1.03	 0.187	 0.273	 190	 1.27	 1.75	 0.379	 0.680
+1	to	+2	 344	 2.88	 1.91	 0.017	 0.069	 312	 −1.79 −0.56	 0.008	 0.260	 162	 5.53	 4.50	 0.127	 0.696
+2	to	+3	 314	 4.72	 3.28	 0.001	 0.014	 223	 −2.81 −1.90	 0.003	 0.009	 172	 9.49	 7.15	 0.002	 0.017
Panel	B:	Changes	in	Performance	Over	Varying	Time	Periods
−1	to	+1	 405	 9.45	 3.83	 0.001	 0.063	 353	 −1.51 −1.59	 0.070	 0.152	 147	 12.76	 6.65	 0.049	 0.184
−1	to	+2	 361	 12.40	 5.22	 0.002	 0.093	 324	 −2.38 −1.05	 0.014	 0.108	 107	 18.72	 13.88	 0.017	 0.086
−1 to +3 317 21.76 8.78 0.000 0.013 262 −2.23 −2.28 0.057 0.263 96 16.52 10.17 0.052 0.172
−4	to	+3	 239	 39.28	 20.71	 0.004	 0.069	 216	 −5.52 −3.80 0.002 0.027 91 23.70 3.16 0.020 0.197
Table 7. Mean	and	Median	Control	Adjusted	Percentage	Changes	in	ROA,	ROS,	and	Operating	Income	with	Control	Firms	Selected	by	Industry,	
Percentage Change in ROA, and Percentage Change in R&D Intensity
   ROA     ROS              Operating Income
     WSR      WSR      WSR 
From year Obs Mean Median p-value	 test	 Obs	 Mean	 Median	 p-value	 test	 Obs	 Mean	 Median	 p-value	 test
Panel	A:	Changes	in	Performance	on	an	Annual	Basis
−4	to	−3	 126	 9.23	 4.07	 0.364	 0.972	 125	 15.60	 9.85	 0.290	 0.772	 187	 13.99	 2.94	 0.059	 0.439
−3 to −2	 111	 27.51	 21.76	 0.097	 0.095	 109	 26.88	 14.27	 0.185	 0.057	 181	 11.46	 10.21	 0.059	 0.031
−2 to −1	 101	 0.60	 0.76	 0.278	 0.484	 103	 6.58	 2.94	 0.063	 0.050	 183	 17.14	 10.57	 0.009	 0.027
−1	to	0	 107	 23.29	 22.41	 0.069	 0.157	 110	 27.53	 13.78	 0.068	 0.021	 149	 14.54	 16.18	 0.084	 0.041
0	to	+1	 82	 19.82	 11.19	 0.326	 0.409	 81	 19.83	 6.76	 0.328	 0.276	 123	 17.38	 6.30	 0.053	 0.123
+1	to	+2	 72	 28.60	 22.39	 0.121	 0.228	 74	 34.91	 23.98	 0.046	 0.081	 110	 16.73	 9.96	 0.076	 0.093
+2	to	+3	 75	 33.75	 26.08	 0.092	 0.042	 74	 30.76	 17.83	 0.069	 0.058	 110	 17.52	 16.88	 0.026	 0.025
Panel	B:	Changes	in	Performance	Over	Varying	Time	Periods
−1	to	+1	 84	 32.13	 20.60	 0.072	 0.072	 84	 34.98	 26.44	 0.067	 0.076	 125	 21.31	 15.41	 0.131	 0.037
−1	to	+2	 79	 42.60	 33.27	 0.050	 0.078	 80	 39.16	 31.66	 0.041	 0.091	 112	 38.71	 14.71	 0.023	 0.070
−1	to	+3	 70	 52.26	 38.42	 0.009	 0.009	 70	 44.06	 31.61	 0.015	 0.025	 93	 49.11	 15.99	 0.016	 0.074
−4	to	+3	 70	 55.40	 45.53	 0.011	 0.023	 74	 78.37	 42.59	 0.001	 0.002	 99	 51.17	 19.10	 0.043	 0.099
14 Z h a n g ,  Y u ,  & X i a  i n  P r o d u c t i o n  a n d  o P e r a t i o n s  M a n a g e M e n t  (2012)
ple firm relative to that of the control firm. To check the 
robustness of our results to the different ways to calculate 
abnormal performance measures, we reran the analyses 
and found the results do not change qualitatively.
Finally, based on other popular ways of choosing con-
trol firms discussed in the literature, we have also run the 
analysis by selecting control firms by industry, firm size, 
and ROA, and by industry and ROA without considering 
the R&D intensity. Results from these additional analyses 
are again similar to those reported earlier.
An alternative explanation to our findings is that, 
rather than a signal of effective innovation programs, 
innovation awards may in themselves create value to 
firms. In other words, receiving innovation awards may 
substantially improve customer perception of the firm, 
leading to a reputational effect. While this mechanism 
may exist, our finding that award-winners continuously 
had better performance even before the announcements 
of the awards suggests that our results are more likely to 
be an outcome of well-designed innovation programs.
6.2. Results from the Panel Regression Analysis
Tables 9 and 10 provide the panel regression results. Ta-
ble 9 shows results from short-term models with 1-year lag 
for R&D intensity, whereas Table 10 shows results of long-
term models with 3-year lags for R&D intensity. Models 
1–6 in both tables report results for each of the six perfor-
mance measures used as the dependent variable. For all 
models, we checked the variance inflation factors (VIFs) 
and found that none of them was greater than 4, indicat-
ing that multicollinearity is not a big concern in our study.
Results in Table 9 show that in the short term, R&D in-
tensity significantly decreases the firm profitability in ROA 
and ROS (Models 1 and 2), largely due to its negative ef-
fect on cost as shown with Model 5. R&D intensity, how-
ever, does not affect operating income, sales, and Tobin’s 
Q in a significant way. On the other hand, award dummy 
is highly significant (p < 0.001) in all six performance mod-
els, suggesting that winning an innovation award does 
contribute to improved firm performance. The interaction 
effect between R&D intensity and award winning is pos-
itive and highly significant in models on ROA and ROS. 
This indicates that besides its direct impact, an effective in-
novation program can also indirectly influence firm per-
formance by streamlining R&D spending.
These findings are robust when we look at the results 
from the long-term models reported in Table 10. For ex-
ample, award dummy is highly significant (p < 0.01) in 
all performance models except the Model 6 for Tobin’s 
Q. There is a significant positive interaction effect be-
tween R&D intensity and award dummy for Models 1 
and 2, again showing the higher returns of award-win-
ning firms. Interestingly, while R&D intensity nega-
tively affects ROA and ROS in the short term, its effect 
on the financial returns is positive and significant in the 
longer term models, suggesting the possible lagged ef-
fect of R&D expenditures on firm performance.
The coefficients for the control variables are generally 
consistent with the existing literature. We observe that 
although larger firms can generate more revenue than 
smaller firms, there is a negative firm size effect on profit-
ability and market value. This supports the argument that, 
as firms grow larger, they become more ossified and less 
adaptive, leading to a lower firm performance (Haveman 
1993). We find alliance connections reduce operating costs 
and increase profitability. This can be explained by the fact 
that interfirm collaboration allows firms to share cost of 
new product development and access to complementary 
assets owned by their partners (Powell 1990). Moreover, 
P&E newness is negatively related to profitability. This 
finding can be attributed to increased operating costs.
Table 8. Mean	and	Median	Control	Adjusted	Percentage	Changes	in	Sales,	Cost,	and	Tobin’s	Q	with	Control	Firms	Selected	by	Industry,	
Percentage Change in ROA, and Percentage Change in R&D Intensity
	 	 	 Sales	 	 	 											Total	cost/sales	 	 	 	 	Tobin’s	Q
     WSR      WSR      WSR 
From Year Obs Mean Median p-value	 test	 Obs	 Mean	 Median	 p-value	 test	 Obs	 Mean	 Median	 p-value	 test
Panel	A:	Changes	in	Performance	on	an	Annual	Basis
−4	to	−3	 316	 12.47	 5.28	 0.002	 0.012	 286	 −0.94	 −0.02	 0.198	 0.955	 148	 5.66	 −6.37 0.190 0.660
−3 to −2	 352	 17.92	 6.03	 0.000	 0.000	 314	 −1.96 −1.00	 0.044	 0.328	 168	 8.15	 2.81	 0.128	 0.961
−2 to −1	 378	 13.12	 7.91	 0.000	 0.000	 346	 −3.00 −1.68	 0.000	 0.003	 150	 9.54	 2.75	 0.102	 0.884
−1	to	0	 353	 10.74	 7.15	 0.000	 0.000	 312	 −1.94	 −0.41	 0.009	 0.074	 154	 11.54	 11.25	 0.066	 0.252
0	to	+1	 265	 6.09	 4.29	 0.005	 0.005	 253	 −1.49	 −1.10	 0.080	 0.340	 123	 7.49	 1.12	 0.147	 0.385
+1 to +2 205 5.99 6.20 0.001 0.001 208 −3.23 −0.82 0.000 0.001 115 9.08 6.77 0.079 0.269
+2 to +3 201 6.72 7.22 0.001 0.003 216 −2.58 −0.86 0.001 0.020 99 9.17 8.57 0.063 0.090
Panel	B:	Changes	in	Performance	Over	Varying	Time	Periods
−1	to	+1	 275	 12.63	 13.66	 0.003	 0.009	 247	 −2.08 −2.34	 0.063	 0.200	 114	 14.42	 16.32	 0.078	 0.463
−1	to	+2	 210	 20.07	 18.46	 0.001	 0.000	 204	 −2.06 −2.88 0.091 0.065 87 17.91 8.59 0.009 0.057
−1	to	+3	 206	 26.41	 20.98	 0.002	 0.014	 184	 −2.77 −3.33	 0.041	 0.093	 70	 21.54	 10.15	 0.015	 0.035
−4	to	+3	 167	 63.57	 33.58	 0.009	 0.065	 146	 −3.52 −2.96 0.030 0.095 66 19.36 3.93 0.152 0.972
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7. Discussion and Conclusion
By analyzing a sample of more than one thousand pub-
licly traded firms that won innovation awards during 
1998–2003, this study empirically tests the influence of 
an effective innovation program on firm performance. 
We find that over an 8-year period from 4 years be-
fore to 3 years after the year of winning the first inno-
vation award, the test sample’s mean (median) change 
in operating income exceeds that of a control sample 
by 39.1% (36.2%). Over the same time span, the con-
trol-adjusted mean (median) changes in ROA and ROS 
are 32.6% (23.5%) and 34.5% (24.1%), respectively. To-
gether, these findings provide strong support to the 
view that an effective innovation program improves 
organizational profitability.
Our evidence also suggests that effective innovation 
programs significantly increase revenue and cost ef-
ficiency. From years −4 to +3, the test sample outper-
forms the control in terms of mean (median) change in 
sales by 39.3% (20.7%), and the mean (median) change 
in cost per dollar of sales is −5.5% (−3.8%) when com-
pared with the control group. Furthermore, the test 
sample has better market valuation; over the period, the 
control-adjusted mean (median) change in Tobin’s Q is 
23.7% (3.16%).
The results from the panel regression analysis are 
largely consistent. Over our study period, the test 
firms persistently outperform the sample firms in 
terms of all six performance criteria. In addition, the 
results show that besides its direct influence, imple-
menting an effective innovation program can also in-
directly contribute to an increase in profitability by 
improving R&D efficiencies.
This study contributes to knowledge about the value 
of effective innovation programs. Of interest to note, 
our event-study results are based on samples matched 
for R&D intensity. Thus, the observed difference in per-
formance is not an outcome of the disparity of R&D 
expenditure, but rather how effectively firms imple-
ment their innovation strategies. In this way, our find-
ings advance understanding of the importance of in-
novation effectiveness, a key aspect of the innovation 
process that has been largely ignored by previous re-
search. Our results also shed light on the on-going de-
bate about whether R&D adequately reflects a firm’s 
innovation activity. Proponents have argued that the 
amount of resources a firm commits to R&D signals its 
innovation effort and strategic orientation. They claim 
that R&D is a reasonable indicator of innovation consid-
ering the fact that firms’ true innovation capabilities are 
often hard to observe directly. Other researchers, how-
ever, stress that R&D is only an input to the innova-
tion process (e.g., Heeley et al. 2007, Kochhar and Da-
vid 1996), and the utility of this measure is constrained 
given the pattern of diminishing return of R&D spend-
ing (Graves and Langowitz 1993). That is, the more a 
firm devotes to R&D, the lower its innovation produc-
tivity. Our study adds to this debate by showing direct 
evidence that firms with similar levels of R&D spend-
ing may have substantially different quality of innova-
tion outputs. Thus, innovation management scholars 
should be cautious about the limitations of R&D-based 
measures. They might consider applying multiple inno-
vation measures at the same time to capture the richness 
and various dimensions of the concept.
The findings reported in the study also offer insights 
to the dynamics of competence construction within or-
ganizations. Danneels points out that while “studies 
consistently showed a positive impact of project-firm 
synergy (the extent to which the project can draw on 
existing in-house resources and skills) on new prod-
uct performance … studies have not considered the 
reverse direction of the product innovation-compe-
tence relation, that is, the effect that new product proj-
ects in turn have on the firm’s competences and its tra-
jectory of renewal” (2002, p. 1096). Through a field 
study of five firms in high-tech sectors, the author de-
tects that the reverse relation does seem to exist (at 
least is salient in the selected firms for that research). 
This finding is consistent with the emerging literature 
on dynamic capabilities, which posits that innovation 
constitutes a meta-capability that assists to “integrate, 
build, and reconfigure” competences for competi-
tive advantages (Teece 2007, Teece et al. 1997, Winter 
2003). Whereas the extant dynamic capabilities litera-
ture on this focus is mostly concerned with how R&D 
affects future product development (e.g., Rothaermel 
and Hess 2007), we concentrate on the impact of inno-
vation on more general firm operations. We find that 
an effective innovation program is beneficial to firms 
in terms of nurturing their abilities to generate revenue 
and sales, to control and reduce operating costs, and to 
attract additional investment by influencing investors’ 
perception of the firms’ future growth opportunities. 
In doing so, we respond to Danneels’s (2002) call for 
more research on the role of innovation in firm compe-
tence development.
Our finding that the award-winning firms experi-
ence significant performance improvement both before 
and after receiving the award are congruent with that of 
Roberts (1999), which demonstrates that innovation pro-
pensity leads to persistent profitability. Whereas Rob-
erts’s study focuses on product innovation in pharma-
ceutical firms, we are able to show that the association 
between innovation and sustained performance is more 
generic in the sense that it is applicable to assorted in-
novations and holds in a wide range of industry con-
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texts. One possible explanation of the sustained compet-
itive advantages is that engaging in effective innovation 
programs permits firms to develop skills in rejuvenat-
ing themselves. This ability, once learned, in turn of-
fers guidelines for firms to stay at a high level of inno-
vativeness. In this regard, a firm’s innovation ability 
is cumulative and path-dependent (Roberts and Amit 
2003). This accounts for why companies, such as Apple, 
Google, IBM, and Procter & Gamble have been contin-
uously ranked as the world’s “most innovative compa-
nies” by Businessweek and other business press. A recent 
analysis of innovation leaders has revealed that these 
companies are successful in delivering “significant and 
sustained growth based on clear strategic ambitions, 
fast exploitation of new insights and effective collabora-
tion across the innovation arena” (Innovaro 2008). These 
firms know not only how to innovate but also how to 
make their innovation processes effective.
There are several limitations with this work. First, not 
all innovation awards were created equal, with some 
awards issued by independent agencies while others are 
offered by a firm to its supplier. This difference could be 
relevant because the awards vary in their evaluation cri-
teria or standards, and thus could have implied different 
levels of innovation. Nevertheless, the results show that 
award winners reap significant financial rewards over 
control firms, regardless of the award type. Second, we 
used company-wide financial data, whereas an award 
might be given to a product or service that is offered by 
an unit of a large firm, which may result in an underes-
timate of the benefits from award-winning events. How-
ever, this is a common practice in similar research due 
to the difficulty in obtaining unit-specific financial per-
formance data (see Hendricks and Singhal 1996, 1997b). 
Third, a firm is likely to win multiple awards from mul-
tiple sources. The number of awards as well as the na-
ture of the award may indicate different levels of per-
formance impact. However, only the first award was 
considered in this study, regardless of the award type. 
This may not be a major limitation as it only makes our 
tests more conservative.
There are several research opportunities for future 
studies. First, our results provoke an important ques-
tion: What accounts for an effective innovation pro-
gram? In other words, why do firms differ in their inno-
vation effectiveness? It is possible that the effectiveness 
of an innovation program depends on the support of 
other organizational systems. For example, Damanpour 
and Evan’s (1984) study indicates that a balance be-
tween technical and social systems is required for opti-
mal innovation outputs. Gibson and Gibbs (2006) show 
that the presence of a well designed virtual network sys-
tem can facilitate team cooperation. As such, future re-
search should examine how these systems may affect (or 
possibly jointly influence) firms’ propensity to receive 
innovation awards. Second, the main focus of the study 
has been on operational and financial performance. Yet 
an equally important issue is how an effective innova-
tion program can enhance firms’ subsequent innovation 
performance. In analyses not reported in this study, we 
regressed patent counts and patent citations on the vari-
ables listed in Tables 9 and 10.9 We find that award win-
ning has significant impact (p < 0.01) on the dependent 
variables in both 1-year lag and 3-year lag models. This 
suggests that award winning is self-reinforcing. These 
results are preliminary and require replication over a 
longer time period. Thus, future research in this direc-
tion is warranted. Third, given our finding of the long-
lasting competitive advantages of effective innovation 
programs, specifying the underlying mechanisms of 
such benefits might be a fruitful avenue for future re-
search. Survey research can be conducted to provide 
an in-depth examination on how awardees successfully 
carry out their innovations. Survey data may also be col-
lected from both award winners and control firms to 
compare their differences in organizational factors and 
implementation process. In addition, as the winning of 
innovation awards is not a direct measure of innova-
tion effectiveness, future survey-based research can help 
generate additional evidence of the validity of using 
award winning as a proxy for the effectiveness of an in-
novation program. Finally, to better understand the role 
of award characteristics, future research might investi-
gate how the type of award, the time of the award, and 
the number of awards are related to firm performance.
Notes
1. Blau and McKinley (1979) also used award winning as an 
indicator of successful innovation in a study of architectural 
firms on the impact of organizational structures and envi-
ronmental characteristics on firm innovativeness. We thank 
an anonymous reviewer for this reference.
2. We checked a number of other innovation awards (e.g., Du-
Pont Awards for Innovation in Packaging, Innovation Excel-
lence Award, Best of What’s New, etc.) and found similar 
requirement for application.
3. Capon et al. (1990) provided a summary of early studies on 
the relevant topic.
4. An extraordinary item is a gain or loss in a firm’s earnings 
due to a non-recurring event that is out of the firm’s control.
5. We distinguish between high-impact-vs.-minor innova-
tions and radical-vs.-incremental innovations. Whereas the 
former classification concerns what degree of social impact 
an innovation has, the latter focuses on the way the inno-
vation is related to previous ones (see Banbury and Mitch-
ell 1995, Jansen et al. 2006). A high-impact innovation can be 
incremental. For example, Microsoft received the Technical 
Innovation Award for its Office 2000 VBA in 2000 and the 
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Software Product of the Year Award for its Office v. X exclu-
sively used in Mac operating system in 2001. These products 
are improved or updated versions of previous offerings.
6. By matching ROA, we provide additional control for the 
possibility that financially successful firms are more likely to 
win innovation awards, although financial performance is 
commonly not a criterion for selection of innovation award 
winners.
7. We thank an anonymous reviewer for pointing out this 
issue.
8. We also constructed a 3-year window alliance variable to 
take account for the possible variation in alliance duration. 
The results are qualitatively the same.
9. The results are available from authors.
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